Genome Editing Using Zinc Finger NucleasesEMBL Heidelberg, Germany Thursday 14 November - Friday 15 November 2013 Registration deadline: Thursday 3 October 2013
Abstract deadline: Thursday 22 August 2013
For an up-to-date list of the confirmed speakers, please click here.
Please note that just before this conference from Monday 11 November until Wednesday 13 November 2013, the EMBL Advanced Course "Targeted Genome Editing Using Zinc Finger Nucleases" will take place at the EMBL Advanced Training Centre in Heidelberg. For more information please click here.
Why You Should Attend
Zinc finger nucleases (ZFNs) enable manipulation of the genome with unprecedented ease and precision. ZFNs are a class of engineered DNA-binding proteins that facilitate targeted editing of the genome by creating double-strand breaks in DNA at user-specified locations. ZFNs have already been used to generate targeted genomic deletions of large segments of DNA in different cell types and organisms like mouse and human cells, plants, fruit flies, zebrafish, and rat. Recently, ZFNs have been used to disrupt or tag genes in human pluripotent stem cells, a system of tremendous interest for genome engineering that was lacking a reliable gene manipulation tool. Featuring keynote presentations, this conference will allow participants to discover the latest applications of transgenics and cell based models for the study of gene regulation and disease. Comprehensive lectures provide in-depth discussion on the fundamentals of ZFNs as well as innovative applications for targeted gene knockout, integration, and tagging. Geared towards scientists interested in learning about the technology, the conference provides researchers at all levels with a unique opportunity for networking with peers. Discussions will facilitate the exchange of ideas to shape the future directions of research in this key area.
- Gene tagging
- Genome editing in stem cells
- Transgenic animal models
- Gene knockout
- Recent advances in ZFN technology
- This conference is organised in cooperation with Sigma-Aldrich.